 
        
        
        
                货号:A686559
                
                同义名:
                    
                        
                            
                                Maytansinoid DM 1; Mertansine
                            
                        
                    
                
                
                
                    
                     
                
            
DM1(Mertansine)是一种微管抑制剂和抗体可结合的美坦新类物质,旨在克服美坦新的全身毒性并增强肿瘤特异性递送。美坦新可以通过连接子附着到单克隆抗体上,以形成抗体-药物结合物(ADC)。
 HazMat Fee +
 HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) | 
| Excepted Quantity | USD 0.00 | 
| Limited Quantity | USD 15-60 | 
| Inaccessible (Haz class 6.1), Domestic | USD 80+ | 
| Inaccessible (Haz class 6.1), International | USD 150+ | 
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ | 
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ | 
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 描述 | Mertansine (DM1) serves as a microtubulin inhibitor and is a maytansinoid designed for conjugation to antibodies to form antibody-drug conjugates (ADCs), aimed at reducing systemic toxicity associated with maytansine and improving tumor-specific delivery[1].[2]. | 
| 体内研究 | Despite its efficacy, mertansine has a relatively low maximum-tolerated dose (MTD) of 1 mg/kg[3]. | 
| 体外研究 | Mertansine demonstrates potent antiproliferative effects against over 60 types of cancer cell lines, showcasing broad chemotherapeutic potential[3]. Mertansine exhibits antitumor activity against malignant B16F10 melanoma cells, particularly when combined with DTX, by inhibiting tumor cell growth through the disruption of mitosis[3]. | 
| Concentration | Treated Time | Description | References | |
| Human hepatocytes | 1.25–2500 nM | 48 hours | To evaluate the inhibitory effects of mertansine on mRNA expression of CYP1A2, CYP2B6, CYP3A4, CYP2C8, CYP2C9, CYP2C19, UGT1A1, UGT1A4, and UGT1A9. Results showed that mertansine dose-dependently suppressed the mRNA levels of these enzymes. | Pharmaceutics. 2020 Mar 2;12(3):220. | 
| Human liver microsomes | 0.01–50 µM | 60 minutes | To evaluate the inhibitory effects of mertansine on UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, and UGT2B7 enzyme activities. Results showed that mertansine inhibited UGT1A1, UGT1A3, and UGT1A4 activities but had no effect on UGT1A6, UGT1A9, and UGT2B7. | Pharmaceutics. 2020 Mar 2;12(3):220. | 
| EL-4 WT cells | 1.71 nM to 416 nM | 72 hours | To evaluate the cytotoxic effect of VHH A1-DM1 on WT cells, results showed no obvious cytotoxicity on WT cells. | Front Immunol. 2024 Mar 14;15:1368586. | 
| EL-4 MICA+ cells | 1.71 nM to 416 nM | 72 hours | To evaluate the cytotoxic effect of VHH A1-DM1 on MICA+ cells, results showed that VHH A1-DM1 had a strong cytotoxic effect on MICA+ cells at low doses, with an IC50 comparable to free DM4. | Front Immunol. 2024 Mar 14;15:1368586. | 
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | A549 tumor xenograft model | Intravenous injection | 0.8 mg/kg | Recorded every 2 days for 15 days | To evaluate the in vivo antitumor efficacy of DM1-loaded ZNPs, results showed a tumor inhibition rate of 97.3%, superior to free DM1's 92.7%. | Drug Deliv. 2020 Dec;27(1):100-109. | 
| C57BL/6 mice | B16-F10 melanoma model | Intraperitoneal injection | 20 nmol/kg | Every 3 days for a total of 5 times | To evaluate the therapeutic effects of M-DM1 in a Mice model of melanoma. Results showed that M-DM1 significantly suppressed tumor growth, prolonged survival, and enhanced the infiltration of CD8+ cytotoxic T cells and NK cells in the tumor microenvironment. | Front Immunol. 2023 Apr 14;14:1178776 | 
| Dose | Rat: 0.48 mg/kg[3] (s.c.) | 
| Administration | s.c. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.35mL 0.27mL 0.14mL | 6.77mL 1.35mL 0.68mL | 13.54mL 2.71mL 1.35mL | |
| CAS号 | 139504-50-0 | 
| 分子式 | C35H48ClN3O10S | 
| 分子量 | 738.29 | 
| SMILES Code | C[C@@H]1[C@@H]2C[C@](O)([C@@H](/C=C/C=C(CC3=CC(N(C(C[C@@H]([C@]4([C@H]1O4)C)OC([C@H](C)N(C)C(CCS)=O)=O)=O)C)=C(Cl)C(OC)=C3)\C)OC)NC(O2)=O | 
| MDL No. | MFCD28398157 | 
| 别名 | Maytansinoid DM 1; Mertansine; UNII-DDZ29HGH0E; DM1 [Maytansinoid]; DM1 Compound; Maytansinoid DM1 | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C | 
| 溶解方案 | DMSO: 60 mg/mL(81.27 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1